Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem Patel

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cureus|February 5, 2021
COVID-19 and Diabetic Ketoacidosis: A Single Center ExperienceBalraj Singh, Parminder Kaur, Prem Patel, et al.
G3 (Bethesda, Md.)|March 13, 2020
DAF-16 and SMK-1 Contribute to Innate Immunity During Adulthood in <i>Caenorhabditis elegans</i>Daniel R McHugh, Elena Koumis, Paul Jacob, et al.
The Journal of Trauma and Acute Care Surgery|April 17, 2026
Aggressive calcium chloride dosing reduces early mortality in trauma patients receiving whole blood resuscitationAashish Rajesh, Lauran Barry, David Limon, et al.
Transplantation|April 1, 2010
Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experienceFrank P Hurst, Imran Sajjad, Eric A Elster, et al.
Molecular Cancer Therapeutics|May 21, 2020
Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal MelanomaJessica L F Teh, Timothy J Purwin, Anna Han, et al.
Indian Heart Journal|January 14, 2023
Clinical outcomes of MANTA vs suture-based vascular closure devices after transcatheter aortic valve replacement: An updated meta-analysisRajkumar Doshi, Rahul Vasudev, Nirmal Guragai, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Cardiometabolic health and the timing of habitual exercise in the All of Us Research ProgramPrem Patel, Connor Riegal, Asanish Kalyanasundaram, et al.
Cancer Discovery|March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Discovery|December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
The British Journal of Ophthalmology|September 21, 2022
Electroretinographic findings in retinal vasculitisHashem H Ghoraba, Wataru Matsumiya, Christopher Or, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cureus|February 5, 2021
COVID-19 and Diabetic Ketoacidosis: A Single Center ExperienceBalraj Singh, Parminder Kaur, Prem Patel, et al.
G3 (Bethesda, Md.)|March 13, 2020
DAF-16 and SMK-1 Contribute to Innate Immunity During Adulthood in <i>Caenorhabditis elegans</i>Daniel R McHugh, Elena Koumis, Paul Jacob, et al.
The Journal of Trauma and Acute Care Surgery|April 17, 2026
Aggressive calcium chloride dosing reduces early mortality in trauma patients receiving whole blood resuscitationAashish Rajesh, Lauran Barry, David Limon, et al.
Transplantation|April 1, 2010
Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experienceFrank P Hurst, Imran Sajjad, Eric A Elster, et al.
Molecular Cancer Therapeutics|May 21, 2020
Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal MelanomaJessica L F Teh, Timothy J Purwin, Anna Han, et al.
Indian Heart Journal|January 14, 2023
Clinical outcomes of MANTA vs suture-based vascular closure devices after transcatheter aortic valve replacement: An updated meta-analysisRajkumar Doshi, Rahul Vasudev, Nirmal Guragai, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Cardiometabolic health and the timing of habitual exercise in the All of Us Research ProgramPrem Patel, Connor Riegal, Asanish Kalyanasundaram, et al.
Cancer Discovery|March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Discovery|December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
The British Journal of Ophthalmology|September 21, 2022
Electroretinographic findings in retinal vasculitisHashem H Ghoraba, Wataru Matsumiya, Christopher Or, et al.
Pageof 5